A detailed history of Psi Advisors, LLC transactions in Haleon PLC stock. As of the latest transaction made, Psi Advisors, LLC holds 147 shares of HLN stock, worth $1,418. This represents 0.0% of its overall portfolio holdings.

Number of Shares
147
Previous 146 0.68%
Holding current value
$1,418
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$8.32 - $10.7 $8 - $10
1 Added 0.68%
147 $1,000
Q2 2024

Jul 23, 2024

BUY
$8.01 - $8.64 $16 - $17
2 Added 1.39%
146 $1,000
Q4 2023

Feb 01, 2024

SELL
$7.78 - $8.62 $7,538 - $8,352
-969 Reduced 87.06%
144 $1,000
Q4 2022

Jan 19, 2023

SELL
$5.96 - $8.06 $5,369 - $7,262
-901 Reduced 44.74%
1,113 $0
Q3 2022

Oct 20, 2022

BUY
$5.63 - $7.5 $11,338 - $15,105
2,014 New
2,014 $12,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.6B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Psi Advisors, LLC Portfolio

Follow Psi Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Psi Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Psi Advisors, LLC with notifications on news.